MUC16 and pancreatic neoplasm: Binding of mesothelin to MUC16 markedly enhances pancreatic cancer cell motility and invasion through selective induction of MMP-7 (one of the molecules most highly expressed in IPF compared to normal lung tissues or those from other ILDs [122]) via a p38 MAPK-dependent pathway [184].